Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:aimsTo |
extend healthy human lifespan
|
| gptkbp:developedBy |
senolytic drugs
|
| gptkbp:focusesOn |
aging
age-related diseases senolytic therapies |
| gptkbp:foundedYear |
2014
|
| gptkbp:founder |
gptkb:John_Lewis
gptkb:Gary_Hudson gptkb:Matthew_Scholz |
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oisin Biotechnologies
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableFor |
targeted removal of senescent cells
|
| gptkbp:technology |
DNA-targeted lipid nanoparticle delivery
|
| gptkbp:website |
https://www.oisinbio.com/
|
| gptkbp:bfsParent |
gptkb:Methuselah_Foundation
gptkb:Laura_Deming |
| gptkbp:bfsLayer |
6
|